AUB
FLGT icon

Atlantic Union Bankshares’s Fulgent Genetics FLGT Stock Holding History

Atlantic Union Bankshares’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59
Closed -$1.55K – 1792
2025
Q4 		$1.55K Buy
+59
New +$1.53K ﹤0.01% 1531

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Atlantic Union Bankshares's FLGT Position: Q1 2026 in Review

Atlantic Union Bankshares sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 59 shares — an estimated $1.55K sold.

Atlantic Union Bankshares first reported a position in FLGT in Q4 2025 and held it in 1 quarter. The position peaked at $1.55K in Q4 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Atlantic Union Bankshares reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Atlantic Union Bankshares sold 59 Fulgent Genetics shares in Q1 2026, an estimated $1.55K.
  • Atlantic Union Bankshares first reported a position in Fulgent Genetics in Q4 2025 and held it in 1 quarter.
  • Atlantic Union Bankshares's Fulgent Genetics position peaked at $1.55K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.